US approves first nasal spray for anaphylaxis

The FDA has approved Neffy, the first adrenaline nasal spray for treating allergic reactions in adults and children over 30 kg. It is a single dose administered into one nostril. Neffy offers a non-invasive alternative to traditional adrenaline injections for emergency situations, including life-threatening reactions.

Source link